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Introduction
Cancer is the second or third cause of death in developing 
countries. It has been estimated that 15 million people will 
die from cancer in 2020 (1). Hematological malignancies 
originate from hematopoietic cells in the bone marrow or 
lymphoid organs (2).
Acute lymphoblastic leukemia (ALL) is the most common 
form of leukemia in the children with the incidence of 40 
per million. Thirty percent of children with cancer under 
15 years old suffer from ALL (3,4).
Although new treatments in last decade improved the 
quality of life, cytotoxic drugs cannot completely cure 
the cancer. On the other hand, their side effects may kill 
some of the patients. Plant derived compounds can help in 
cancer treatment by growth inhibition (5). 
Recently, scientists are trying to find out natural 
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Implication for health policy/practice/research/medical education:
EGCG has anti-cancer properties against different cell lines and this effect seems to be through apoptosis induction in lymphoblastic 
leukemia. These results can be a step toward targeted combination or alternative chemotherapy in cancer.
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Introduction: Acute lymphoblastic leukemia (ALL) is one of the malignant proliferations of 
lymphoid cells in the early stages of differentiation and accounts for ¾ of all cases of childhood 
leukemia. Available treatment cannot completely treat this disease. Epigallocatechin-3-gallate 
(EGCG) is a polyphenolic compounds in the green tea that has demonstrated to have anticancer 
and antimitotic properties. The purpose of the present study was the evaluation of the effect 
of EGCG on the proliferation inhibition and apoptosis induction in a lymphoblastic leukemia 
cell line.
Methods: Jurkat cell line was cultured in standard condition and in different concentrations of 
EGCG (0-100 micromolar) for 24, 48 and 72 hours. Cell viability was measured by MTS assay. 
Apoptosis induction was assessed by annexin V-FITC and flow cytometry analysis. 
Results: The MTS assay revealed that EGCG has decreased cell viability with a time and dose 
dependent manner. The level of cell apoptosis in all used concentrations of EGCG (50, 70 and 
100 µm) was higher than control group (71%, 40% and 31% respectively vs. 8%) and reached to 
significant level at 100 µm concentration. 
Conclusion: The study indicated that EGCG is effective on proliferation inhibition and apoptotic 
induction in Jurkat lymphoblastic cell line. Therefore, the study of the mechanism of apoptosis 
induction could be a step of progress toward target therapy which might be considered in the 
future studies.
A R T I C L E  I N F O
Keywords:
EGCG
Proliferation
Jurkat cell line
Acute lymphoblastic leukemia
Apoptosis
Article History:
Received: 13 December 2014
Accepted: 7 February 2015
Article Type:
Original Article
A B S T R A C T
Ghasemi-Pirbaluti M et al.
Journal of HerbMed Pharmacology, Volume 4, Number 2, April 2015 http://www.herbmedpharmacol.com 66
compounds and their derivatives to treat different 
diseases including cancer. Many studies have shown that 
plant derivatives are apoptotic inducer that can inhibit 
cancer (6). 
Above 60% of available anticancer drugs have been derived 
from plants, plants organs or have microbial origin (7). 
Epigallocatechin-3-gallate (EGCG) is a polyphenolic 
compound with anticancer properties against many cell 
lines including (8) B cell lymphoblastic leukemia (9). 
EGCG has been found to potentiate the inhibitory effect 
of Ziziphus extracts on hepatocarcinoma cells (10). 
Apoptotic pathway is an important target in effective 
treatment of cancer (11). Previous studies indicated that 
EGCG could inhibit splenic B lymphocyte (12) and mice 
lymphocyte proliferation (13). On the other report, this 
compound can induce neopterine (an immunological 
marker) in mononuclear cell in blood (14). 
To the best of our knowledge, there is no study describing 
the effect of EGCG on lymphoblastic leukemia cell line. 
Evaluation of the effect of EGCG on lymphoblastic cells 
and its effective doses can help to identify of the anticancer 
properties of polyphenolic compounds. 
This study was aimed to investigate the effects of 
physiological and pharmacological concentrations of 
EGCG on Jurkat lymphoblastic leukemia cell line. 
Materials and Methods
A lymphoblastic cell line (Jurkat E6.1) was grown in 
RPMI-1640 culture medium supplemented with 0.3 mg/
ml glutamine, 10% fetal calf serum, 100 IU penicillin and 
100 µg streptomycin, and kept at 37°C in a humidified 
atmosphere containing 5% CO2. Cells in the exponential 
phase were used for all experiments. Cell count was 
performed by hemocytometer and tripan blue dye.
Analysis of cell viability (MTS assay)
MTS/PMS was used to assay viability and proliferation 
of the cell line according to Thabrew method (15). 
Briefly, cells at 1×104 cell/ml were cultured in 96-well 
flat-bottomed tissue culture plate. The cells were treated 
with EGCG (0-100 micromolar) for 24, 48 and 72 hours 
in 37°C, 5% CO2 and humidified atmosphere. At the 
end of the experiment, MTS/PMS solution was added to 
each well and cells were incubated for 2 hours at 37°C in 
a dark place. The absorbance at 490-620 nm was assessed 
using ELISA reader (stat fax-2100 awareness). Each 
independent experiment was repeated at least tree times 
and the concentration required for a 50% inhibition of 
growth (IC50) was determined.
Annexin V/PI assay
Apoptosis was examined by flow-Cytometry with the FITC 
Annexin V Apoptosis Detection Kit (BD Pharmingen). 
Briefly, the cells were treated with different concentrations 
of EGCG. Then the cells were harvested and washed in 
PBS twice. 106 cells were re-suspended in 1 ml 1 X binding 
buffer. 105 cells were incubated with 5 µl of FITC-labeled 
annexin V and 1 µl of 100 µg/ml PI (propidium iodide) 
at room temperature in dark place for 20 minutes, then 
400 µl of 1 X binding buffer were added. The tube mixed 
gently, and kept on ice and analyzed by flow-Cytometry 
equipment (PARTEC).
Statistical analysis 
All data are presented as mean±SEM. Calculations and 
statistical tests were performed using SPSS (SPSS) and 
GraphPad Prism (v5.01, USA). Comparisons of data were 
made using Kruskal–Wallis test. A P≤0.05 was considered 
significant. All experiments were repeated at least 3 times.
Results
EGCG significantly decreased cell proliferation in Jurkat 
line after 24, 48 and 72 hours incubation. The ratios of 
viable cells to control ones were 22%, 51% and 60% in 
50, 70 and 100 micromolar concentrations, respectively 
after 48 hours. The ratios of viable cells to control ones 
were 16%, 38% and 52% in 50, 70 and 100 micromolar 
concentrations, respectively after 72 hours (Figure 1).
Effect of different concentration of EGCG on apoptosis
EGCG was effective in different concentrations on the cell 
line and the drug induced apoptosis successfully, shown 
by MTS/PMS assay. Apoptosis was increased significantly 
after treatment with different concentrations of EGCG 
compared to control group. 
Figure 2 shows the percent of Jurkat cell apoptosis in the 
presence of 70 micromolar concentration of ECGC. 50, 
70 and 100 micromolar concentrations of EGCG induced 
apoptosis in 31%, 40% and 71% of the cells, respectively 
(Figure 3).
Discussion
Apoptosis is the process of cell self destruction (PCD) 
that may occur in multicellular organisms. Biochemical 
events lead to characteristic cell changes (morphology), 
the fragmentation of nuclear DNA and death. Decrease in 
apoptosis rate can lead frequently to genetic change and 
cancer (16).
The study investigated the anti-proliferative effects of 
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Figure 1. Effect of different concentrations of EGCG on viability of 
Jurkat cell line after 24, 48, and 72 hours.
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EGCG on Jurkat cell line.
According to the results of MTS/PMS assay, different 
concentrations of EGCG decreased viability of Jurkat 
cells, dose and time dependently. 
Sturgeon et al showed that green tea can notably decrease 
incidence and improve prognosis of some cancers 
including intestine, lung, pancreatic, and prostate cancers 
(17). Previous studies have shown the antioxidant 
properties of green tea against oxidative induced DNA 
damage or lipid and protein oxidation (18). 
Annabi et al. reported that EGCG inhibited expression 
of MMP-9 gene, which had a significant role in cancer 
cell growth and metastasis, in HL-60 myeloid human 
leukemia cells (19). 
Smith et al found that the EGCG inhibits DNA replication 
in different leukemia cell lines including HL-60. EGCG 
is the most potent in S phase compared to other cellular 
phase (20).
Our study indicated that EGCG inhibited successfully 
the proliferation of Jurkat cells and induced cell apoptosis 
at different concentrations. Apoptosis in lymphoblastic 
Jurkat cells is a suitable model for mechanistic 
investigation of the EGCG on cell growth. EGCG has 
inhibitory effect in MCF-7 (breast cancers cells) and 
HL60 promyelocytic leukemia cells (21). The results of 
our study are in agreement with the other studies results. 
In our study, we observed that EGCG could induce dose 
dependently apoptosis in Jurkat cells, similar to previous 
studies in other cancer cell lines. 
Conclusion
The Results of the study showed that EGCG is effective 
in proliferation and apoptosis induction in Jurkat cell 
line. The drug can be considered as a potential for 
lymphoblastic leukemia chemotherapy. The study of the 
mechanism of apoptosis in lymphoblastic cell lines besides 
in vivo studies in experimental models can be a progress 
toward targeted chemotherapy in cancer. 
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Figure 2. Flow cytrometric analysis of apoptosis of Jurkat cells treated with EGCG (black curve) compared to control cells (gray curve). 
Percents of apoptosis were 8% and 40%, respectively in control and EGCG groups.
Figure 3. The effect of different concentrations of EGCG on 
Jurkat cell apoptosis after 48 hours incubation compared to 
control group (**P<0.01 show the significant difference).
co
nt
ro
l
5 0 70 10
0
0
2 0
4 0
6 0
8 0 **
P= 0.016
Concentration(M)
ap
op
to
sis
(%
)
 
Ghasemi-Pirbaluti M et al.
Journal of HerbMed Pharmacology, Volume 4, Number 2, April 2015 http://www.herbmedpharmacol.com 68
Funding/Support 
This research was financially supported by Shahrekord 
University of Medical Sciences, Shahrekord, Iran.
References
1. Mignogna MD, Fedele S, Lo Russo L. The World 
Cancer Report and the burden of oral cancer.Eur J 
Cancer Prev. 2004;13(2):139-42. 
2. McPherson RA, Pincus MR. Henry’s Clinical 
diagnosis and managmant by laboratory methods.
Translated to Persian by: Mohseni A. Tehran: 
Artinteb;2011. p.230
3. Gurney JG, Severson RK, Davis S, Robison LL. 
Incidence of cancer in children in the United States. 
Sex-, race-, and 1-year age-specific rates by histologic 
type. Cancer 1995;(75): 2186–2195.
4. Pui CH, Evans WE. Acute lymphoblastic leukemia. N 
Engl J Med 1998;33:605-15.
5. Shashi B, Jaswant S, Madhusudana RJ, Kumar 
SA, Nabi QG. A novel lignan composition from 
Cedrusdeodara induces apoptosis and early nitric 
oxide generation in human leukemia Molt-4 and HL-
60 cells. Nitric Oxide. 2006;14(1):72-88.
6. Schilling T, Kairat A, Melino G, Krammer PH, 
Stremmel W, Oren M, et al. Interference with the p53 
family network contributes to the gain of oncogenic 
function of mutant p53 in hepatocellular carcinoma. 
Biochem Biophys Res Commun. 2010;394(3):817-23.
7. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin 
IN, et al. Bcl-2 overexpression attenuates resveratrol-
induced apoptosis in U937 cells by inhibition of 
caspase-3 activity. Carcinogenesis. 2001;22(10):1633.
8. Lambert JD, Elias RJ. The antioxidant and pro-oxidant 
activities of green tea polyphenols: a role in cancer 
prevention. Arch Biochem Biophys. 2010;501(1):65-
72.
9. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek 
DF, Kay NE. VEGF receptor phosphorylation status 
and apoptosis is modulated by a green tea component, 
epigallocatechin-3-gallate (EGCG), in B-cell chronic 
lymphocytic leukemia. Blood. 2004;104(3):788-94. 
10. Huang X, Kojima-Yuasa A, Xu S, Norikura T, Kennedy 
DO, Hasuma T, et al. Green tea extract enhances the 
selective cytotoxic activity of Zizyphusjujuba extracts 
in HepG2 cells. Am J Chin Med. 2008;36(4):729-44
11. Denicourt C, Dowdy SF. Targeting apoptotic pathways 
in cancer cells. Science. 2004;305(5689):1411-3
12. Hu ZQ, Toda M, Okubo S, Hara Y, Shimamura T. 
Mitogenic activity of(-)epigallocatechin gallateon 
B-cells and investigation of its structure function 
relationship. Int J Immunopharmacol. 1992;14:1399–
407.
13. Wilasrusmee C, Kittur S, Siddiqui J, Bruch D, 
Wilasrusmee S, Kittur DS. In vitro immunomodulatory 
effects of ten commonly used herbs on murine 
lymphocytes. J Altern Complement Med. 
2002;8:467–75.
14. Zvetkova E, Wirleitner B, Tram NT, Schennach H, 
Fuchs D. Aqueous extracts of Crinum latifolium (L) 
and Camellia sinensis show immunomodulatory 
properties in human peripheral blood mononuclear 
cells. Int Immuno Pharmacol. 2001;1:2143–50.
15. Thabrew MI, Hughes RD, McFarlane IG. Screening 
of hepatoprotective plant components using a 
HepG2 cell cytotoxicity assay. J Pharm Pharmacol. 
1997;49(11):1132-5.
16. Hoffbrand VA, Moss PH. Essential Hematology. 
Translated to Persian by: Pourgheysari B. Tehran: 
Asaresobhan;2011. p.230.
17. Sturgeon JL, Williams M, van Servellen G. Efficacy of 
green tea in the prevention of cancers. Nurs Health 
Sci. 2009;11(4):436-46.
18. Ellinger S, Mller N, Stehle P, Ulrich-Merzenich G. 
Consumption of green tea or green tea products: 
is there an evidence for antioxidant effects from 
controlled interventional studies? Phytomedicine. 
2011;18(11):903-15.
19. Annabi B, Currie JC, Moghrabi A, Bliveau R. 
Inhibition of HuR and MMP-9 expression in 
macrophage-differentiated HL-60 myeloid leukemia 
cells by green tea polyphenol EGCG. Leuk Res. 
2007;31(9):1277-84
20. Smith DM, Dou QP. Green tea polyphenol 
epigallocatechin inhibits DNA replication and 
consequently induces leukemia cell apoptosis. Int J 
Mol Med. 2001;7(6):645-52
21. Berletch JB, Liu C, Love WK, Andrews LG, Katiyar SK, 
Tollefsbol TO. Epigenetic and genetic mechanisms 
contribute to telomerase inhibition by EGCG. J Cell 
Biochem. 2008;103(2):509-19
